X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9222) 9222
Publication (349) 349
Newsletter (154) 154
Newspaper Article (104) 104
Book Review (56) 56
Magazine Article (36) 36
Dissertation (24) 24
Book Chapter (16) 16
Conference Proceeding (7) 7
Transcript (3) 3
Web Resource (3) 3
Trade Publication Article (2) 2
Book / eBook (1) 1
Government Document (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5513) 5513
ranitidine (4992) 4992
male (4028) 4028
female (3201) 3201
adult (2697) 2697
middle aged (2310) 2310
ranitidine - therapeutic use (2235) 2235
pharmacology & pharmacy (1553) 1553
aged (1512) 1512
ranitidine - pharmacology (1467) 1467
gastroenterology & hepatology (1466) 1466
omeprazole (1440) 1440
animals (1370) 1370
ranitidine - administration & dosage (1157) 1157
cimetidine (1092) 1092
anti-ulcer agents - therapeutic use (1082) 1082
double-blind method (917) 917
duodenal ulcer - drug therapy (881) 881
rats (853) 853
histamine h2 antagonists - therapeutic use (789) 789
histamine h2 antagonists - pharmacology (729) 729
index medicus (715) 715
omeprazole - therapeutic use (705) 705
time factors (674) 674
adolescent (661) 661
ranitidine - adverse effects (642) 642
cimetidine - pharmacology (627) 627
drug therapy, combination (618) 618
helicobacter pylori (604) 604
proton pump inhibitors (595) 595
treatment outcome (577) 577
helicobacter infections - drug therapy (575) 575
hydrogen-ion concentration (573) 573
recurrence (551) 551
cimetidine - therapeutic use (545) 545
dose-response relationship, drug (500) 500
prospective studies (489) 489
famotidine (475) 475
clinical trials as topic (461) 461
anti-ulcer agents - administration & dosage (456) 456
medicine, general & internal (456) 456
histamine (455) 455
drug interactions (437) 437
gastric acid - metabolism (435) 435
drug administration schedule (414) 414
lansoprazole (407) 407
therapy (406) 406
stomach ulcer - drug therapy (404) 404
administration, oral (400) 400
gastric mucosa - drug effects (398) 398
gastroesophageal reflux - drug therapy (390) 390
peptic ulcer - drug therapy (387) 387
gastric acid - secretion (383) 383
duodenal-ulcer (379) 379
histamine h2 antagonists - administration & dosage (376) 376
double-blind (370) 370
aged, 80 and over (369) 369
gastric acidity determination (368) 368
disease (367) 367
gastroesophageal reflux (338) 338
random allocation (338) 338
omeprazole - administration & dosage (334) 334
duodenal ulcer (331) 331
pharmacokinetics (328) 328
2-pyridinylmethylsulfinylbenzimidazoles (303) 303
prevention (295) 295
drugs (289) 289
omeprazole - analogs & derivatives (289) 289
anti-ulcer agents - pharmacology (287) 287
follow-up studies (278) 278
risk factors (268) 268
esophagitis (262) 262
infection (261) 261
antacids - therapeutic use (259) 259
gastroenterology and hepatology (257) 257
kinetics (256) 256
surgery (256) 256
eradication (255) 255
anti-ulcer agents - adverse effects (250) 250
anti-bacterial agents - therapeutic use (249) 249
omeprazole - pharmacology (245) 245
sucralfate (245) 245
esophagitis, peptic - drug therapy (238) 238
histamine - pharmacology (237) 237
child (230) 230
cimetidine - administration & dosage (227) 227
peptic ulcer (227) 227
rats, wistar (225) 225
histamine h2 antagonists - adverse effects (223) 223
ranitidine hydrochloride (218) 218
gastrins - blood (215) 215
gastric mucosa - metabolism (213) 213
ranitidine - pharmacokinetics (210) 210
research (210) 210
secretion (210) 210
analysis (207) 207
cross-over studies (204) 204
ranitidine - analogs & derivatives (204) 204
peptic-ulcer (201) 201
efficacy (199) 199
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8497) 8497
German (291) 291
French (196) 196
Spanish (154) 154
Italian (122) 122
Japanese (107) 107
Russian (58) 58
Chinese (45) 45
Portuguese (39) 39
Polish (33) 33
Korean (32) 32
Dutch (17) 17
Hungarian (12) 12
Danish (11) 11
Turkish (11) 11
Romanian (10) 10
Czech (6) 6
Persian (6) 6
Bulgarian (5) 5
Croatian (5) 5
Hebrew (5) 5
Norwegian (5) 5
Swedish (5) 5
Arabic (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuroscience Letters, ISSN 0304-3940, 02/2015, Volume 587, p. 57
* The H.sub.2 receptor agonist dimaprit facilitates memory retention of inhibitory avoidance. * The H.sub.2 receptor antagonist ranitidine inhibits inhibitory... 
Ranitidine
Journal Article
06/2014
In previous research, ranitidine has formed high yields of the disinfection by-product N-Nitrosodimethylamine (NDMA) upon chloramination. In the current... 
0543 | Ranitidine | Cations | NDMA
Dissertation
Nutrition clinique et metabolisme, ISSN 0985-0562, 05/2018, Volume 32, Issue 2, p. 109
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.nupar.2017.12.003 Un... 
Nutrition | Ranitidine
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 10/2008, Volume 25, Issue 10, pp. 2327 - 2333
The aim of this study was to investigate the effects of different doses of polyethylene glycol 400 (PEG 400) on the bioavailability of ranitidine in male and... 
Biochemistry, general | gender | permeability | gastrointestinal transit | Biomedical Engineering | Biomedicine | H 2 receptor antagonists | Pharmacy | Medical Law | solubility | metabolism | efflux transporters | Pharmacology/Toxicology | excipients | oral absorption | Oral absorption | Excipients | receptor antagonists | Solubility | Gastrointestinal transit | Gender | Permeability | Metabolism | Efflux transporters | GUT TRANSIT | ABSORPTIVE TRANSPORT | H-2 receptor antagonists | CHEMISTRY, MULTIDISCIPLINARY | H-2-RECEPTOR ANTAGONISTS | CATION RANITIDINE | P-GLYCOPROTEIN | IN-VITRO | PHARMACOLOGY & PHARMACY | SEX-DIFFERENCES | GENDER-DIFFERENCES | CANCER RESISTANCE PROTEIN | Ranitidine - chemistry | Administration, Oral | Ranitidine - pharmacokinetics | Humans | Intestinal Absorption - drug effects | Biological Availability | Male | Polyethylene Glycols - chemistry | Ranitidine - urine | Histamine H2 Antagonists - pharmacokinetics | Chemistry, Pharmaceutical | Histamine H2 Antagonists - chemistry | Cross-Over Studies | Dose-Response Relationship, Drug | Histamine H2 Antagonists - administration & dosage | Excipients - chemistry | Biotransformation | Sex Factors | Adult | Excipients - pharmacology | Female | Ranitidine - administration & dosage | Histamine H2 Antagonists - urine | Polyethylene Glycols - pharmacology | Football (College) | Metabolites | Polyethylene glycol | Ranitidine | Comparative studies | Pharmacology | Gender differences | Kinetics | Drug dosages
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 01/2012, Volume 9, Issue 1, pp. 14 - 28
As 95% of all prescriptions are for orally administered drugs, the issue of oral absorption is central to the development of pharmaceuticals. Oral absorption... 
ranitidine | mucoadhesion | hydrophobic drugs | griseofulvin | cyclosporin A | idarubicin | chitosan amphiphiles | hydrophilic drugs | transcellular transport | oral absorption | AQUEOUS-SOLUTIONS | PERMEABILITY | VESICLES | MONOLAYERS | P-GLYCOPROTEIN | DELIVERY | IN-VITRO | TRANSPORT | CYCLOSPORINE-A | EPITHELIAL CACO-2 CELLS | PHARMACOLOGY & PHARMACY | Intestinal Mucosa - metabolism | Nanoparticles - chemistry | Rats, Wistar | Ranitidine - pharmacokinetics | Humans | Drug Carriers - administration & dosage | Idarubicin - pharmacokinetics | Male | Drug Carriers - analysis | Anti-Ulcer Agents - blood | Quaternary Ammonium Compounds - chemistry | Griseofulvin - blood | Intestinal Absorption | Anti-Ulcer Agents - pharmacokinetics | Cyclosporine - blood | Intestinal Mucosa - cytology | Griseofulvin - pharmacokinetics | Griseofulvin - metabolism | Antifungal Agents - pharmacokinetics | Antifungal Agents - metabolism | Cyclosporine - pharmacokinetics | Idarubicin - administration & dosage | Antibiotics, Antineoplastic - pharmacokinetics | Chitosan - analogs & derivatives | Cyclosporine - metabolism | Griseofulvin - administration & dosage | Caco-2 Cells | Idarubicin - metabolism | Drug Carriers - metabolism | Adhesiveness | Nanoparticles - ultrastructure | Rats | Anti-Ulcer Agents - administration & dosage | Ranitidine - metabolism | Antibiotics, Antineoplastic - administration & dosage | Animals | Chitosan - chemistry | Ranitidine - blood | Intestine, Small - cytology | Anti-Ulcer Agents - metabolism | Cyclosporine - administration & dosage | Hydrophobic and Hydrophilic Interactions | Drug Carriers - pharmacokinetics | Intestine, Small - metabolism | Ranitidine - administration & dosage | Antibiotics, Antineoplastic - metabolism | Antifungal Agents - administration & dosage | Antifungal Agents - blood
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2018, Volume 39, p. A223
La mastocytose resulte d'une proliferation clonale de mastocytes anormaux dans la peau uniquement (mastocytose cutanee) ou dans un ou plusieurs organes... 
Fainting | Psoriasis | Ranitidine
Journal Article
Pediatrics, ISSN 0031-4005, 2012, Volume 129, Issue 1, pp. e40 - e45
BACKGROUND AND OBJECTIVES: Gastric acidity is a major nonimmune defense mechanism against infections. The objective of this study was to investigate whether... 
Pneumonia | Very low birth weight | Histamine-2 receptor antagonists | Microflora | Sepsis | Urinary tract infections | Gastric acidity inhibitors | RISK-FACTORS | gastric acidity inhibitors | very low birth weight | GASTROINTESTINAL-TRACT | PRETERM INFANTS | CLOSTRIDIUM-DIFFICILE | GASTRIC-ACIDITY INHIBITORS | histamine-2 receptor antagonists | GASTROESOPHAGEAL-REFLUX | BIRTH-WEIGHT INFANTS | pneumonia | INTENSIVE-CARE-UNIT | urinary tract infections | PEDIATRICS | sepsis | BLOOD-STREAM INFECTIONS | microflora | Anti-Ulcer Agents - therapeutic use | Infant, Premature, Diseases - prevention & control | Infant, Very Low Birth Weight | Bacterial Infections - etiology | Humans | Risk Factors | Anti-Ulcer Agents - adverse effects | Histamine H2 Antagonists - adverse effects | Peptic Ulcer - prevention & control | Male | Infant, Premature, Diseases - mortality | Histamine H2 Antagonists - therapeutic use | Gastric Acid - secretion | Bacterial Infections - immunology | Infant, Premature, Diseases - chemically induced | Enterocolitis, Necrotizing - chemically induced | Infant, Premature | Female | Ranitidine - adverse effects | Infant, Newborn | Infant, Premature, Diseases - immunology | Ranitidine - therapeutic use | Infants (Newborn) | Drugs | Enterocolitis, Pseudomembranous | Complications and side effects | Care and treatment | Enterocolitis, Neonatal necrotizing | Ranitidine | Causes of | Product/Service Evaluations | Health aspects | Pediatrics | Infections | Birth weight | Newborn babies | Drug therapy
Journal Article
Pediatrics, ISSN 0031-4005, 05/2006, Volume 117, Issue 5, pp. e817 - e820
Journal Article
Brain Research, ISSN 0006-8993, 02/2002, Volume 926, Issue 1-2, pp. 172 - 175
The blockade of central histaminergic H sub(2) receptors has been reported to aggravate ischemic neuronal damage. Since excess release of excitatory... 
ranitidine
Journal Article
Journal Article
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 09/2014, Volume 98, p. 113
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 06/2017, Volume 38, p. A150-A151
La famille des inhibiteurs de la pompe a protons (IPP) represente un traitement medicamenteux prescrit en tres grande quantite en raison de son efficacite, sa... 
Protons | Electrocardiography | Electrocardiogram | Ranitidine
Journal Article
Environment International, ISSN 0160-4120, 2009, Volume 35, Issue 5, pp. 821 - 825
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 2/2017, Volume 73, Issue 2, pp. 185 - 195
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 05/2017, Volume 17, Issue 1, pp. 375 - 6
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 02/2014, Volume 54, Issue 2, pp. 201 - 205
Journal Article